| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chairperson &CEO
1 company
Rothblatt Martine A is a Chairperson &CEO at UTHR. Recent filings cover 0 purchases and 462 sales. Those positions are worth an estimated $175.2M at current prices.
Our model assigns Rothblatt Martine A a middling insider score of 58/100, based on 304 past trades. Over a 12-month horizon, 53.6% of those trades were profitable, with an average 12-month return of -1.6%.
Rothblatt Martine A's largest disclosed position is in UTHR as Chairperson &CEO, worth about $175.2M. The recent filings there lean toward selling, a net 355,916 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Oct 2, 2026 | UTHR United Therapeutics Corporation | Chairperson &CEO | Sale+OE | 7,680 | $551.35 | $4,234,332.04 | -2.3% | |
| Oct 1, 2026 | UTHR United Therapeutics Corporation | Chairperson &CEO | Sale+OE | 9,500 | $576.47 | $5,476,462.44 | -2.8% | |
| Sep 30, 2026 | UTHR United Therapeutics Corporation | Chairperson &CEO | Sell | 1,640 | $548.64 | $899,772.21 | -0.5% | |
| Sep 30, 2026 | UTHR United Therapeutics Corporation | Chairperson &CEO | Sale+OE | 7,910 | $522.11 | $4,129,860.82 | -2.4% | |
| Sep 29, 2026 | UTHR United Therapeutics Corporation | Chairperson &CEO | Sale+OE | 9,500 | $477.42 | $4,535,479.91 | -2.8% | |
| Sep 28, 2026 | UTHR United Therapeutics Corporation | Chairperson &CEO | Sale+OE | 9,500 | $480.85 | $4,568,106.27 | -2.8% | |
| Sep 25, 2026 | UTHR United Therapeutics Corporation | Chairperson &CEO | Sale+OE | 9,500 | $476.17 | $4,523,635.17 | -2.8% | |
| Sep 24, 2026 | UTHR United Therapeutics Corporation | Chairperson &CEO | Sale+OE | 9,980 | $472.18 | $4,712,351.71 | -3.0% | |
| Sep 23, 2026 | UTHR United Therapeutics Corporation | Chairperson &CEO | Sale+OE | 9,500 | $491.57 | $4,669,917.54 | -2.8% | |
| Sep 22, 2026 | UTHR United Therapeutics Corporation | Chairperson &CEO | Sale+OE | 9,500 | $494.83 | $4,700,850.58 | -2.8% |